Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Nobuhiro Hiramoto"'
Autor:
Tomohiro Yabushita, Yoshimitsu Shimomura, Hayato Maruoka, Daisuke Katoh, Daisuke Yamashita, Hironaga Satake, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Momoko Nishikori, Takeshi Morimoto, Yukihiro Imai, Takayuki Ishikawa
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 698-708 (2024)
Abstract Somatic hypermutations (SHMs) in the variable region (VH) of the immunoglobulin heavy chain (IgH) gene are common in diffuse large B‐cell lymphoma (DLBCL). Recently, IgH VH SHMs have become known as immunogenic neoantigens, but few studies
Externí odkaz:
https://doaj.org/article/b22f7b1979c24583aac4b6c56dc70b75
Autor:
Ryosuke Naka, Yoshimitsu Shimomura, Madoka Kanda‐Kato, Nobuhiro Hiramoto, Shigeo Hara, Takayuki Ishikawa
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 829-832 (2023)
Abstract Monoclonal gammopathy of undetermined significance (MGUS) is a benign but precancerous condition that can progress to multiple myeloma. Patients with MGUS are typically monitored closely for signs of disease progression, but in some cases, t
Externí odkaz:
https://doaj.org/article/ba43d3cdc90b456587d9570a6610a79c
Autor:
Naoki Okada, Ryusuke Yamamoto, Hayato Maruoka, Mayuko Himeno, Nobuhiro Hiramoto, Takayuki Ishikawa
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 604-612 (2023)
T-cell prolymphocytic leukemia (T-PLL) is a rare aggressive disease with a poor prognosis. Allogeneic stem cell transplantation (allo-SCT) followed by alemtuzumab administration is the most promising treatment for T-PLL but is associated with a high
Externí odkaz:
https://doaj.org/article/46dc5f994c1a435e8bf84e4556da82fd
Autor:
Tomohiko Yamada, Nobuhiro Hiramoto, Takuto Mori, Daisuke Yamashita, Yukimasa Tai, Ryusuke Yamamoto, Masashi Nishikubo, Hayato Maruoka, Kana Sakamoto, Kengo Takeuchi, Yasuhito Nannya, Seishi Ogawa, Takayuki Ishikawa
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/3050194baa724f22a730baa3ec07fc42
Autor:
Yotaro Ochi, Yasuhito Nannya, Senji Kasahara, Nobuhiro Hiramoto, Nobuhiro Kanemura, Nobuo Sezaki, Maki Sakurada, Makoto Iwasaki, Junya Kanda, Yasunori Ueda, Satoshi Yoshihara, Masahiro Nakagawa, Ryunosuke Saiki, Akinori Yoda, Rurika Okuda, Masanori Motomura, Yuichi Shiraishi, Takayuki Ishikawa, Satoru Miyano, Akifumi Takaori, Seishi Ogawa
Publikováno v:
HemaSphere, Vol 7, p e663766a (2023)
Externí odkaz:
https://doaj.org/article/6197e27c11f64b5ab413467f2770fe75
Autor:
Minoru Kanaya, Daigo Hashimoto, Hirohisa Nakamae, Takahide Ara, Takahiro Fukuda, Koji Nagafuji, Tetsuya Eto, Nobuhiro Hiramoto, Yumiko Maruyama, Shuichi Ota, Ken-Ichi Matsuoka, Takashi Akasaka, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima
Publikováno v:
HemaSphere, Vol 7, p e4940030 (2023)
Externí odkaz:
https://doaj.org/article/dd89f0b095ab4bf6bcccf114170e854f
Autor:
Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Satoshi Yoshioka, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, Satoshi Mitsuyuki, Tomoyo Kubo, Naoki Okada, Daishi Nakagawa, Kimimori Kamijo, Hiroharu Imoto, Yuya Nagai, Nobuhiro Hiramoto, Noboru Yonetani, Tadakazu Kondo, Chisato Miyakoshi, Asako Doi, Takayuki Ishikawa
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/24881e0ff2e641a688c8aaa3da0a4fdb
Autor:
Masashi Nishikubo, Yoshimitsu Shimomura, Nobuhiro Hiramoto, Naohiko Sawamura, Takako Yamaguchi, Shigeo Hara, Takayuki Ishikawa
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-6 (2021)
Abstract Background Gemcitabine and cisplatin are chemotherapeutic agents used for treating multiple cancers, and these agents are sometimes used in combination. Drug-induced thrombotic microangiopathy (TMA) is a rare but potentially fatal complicati
Externí odkaz:
https://doaj.org/article/8a2b8a430853462da77da71c8290823a
Autor:
Yotaro Ochi, Kenichi Yoshida, Ying-Jung Huang, Ming-Chung Kuo, Yasuhito Nannya, Ko Sasaki, Kinuko Mitani, Noriko Hosoya, Nobuhiro Hiramoto, Takayuki Ishikawa, Susan Branford, Naranie Shanmuganathan, Kazuma Ohyashiki, Naoto Takahashi, Tomoiku Takaku, Shun Tsuchiya, Nobuhiro Kanemura, Nobuhiko Nakamura, Yasunori Ueda, Satoshi Yoshihara, Rabindranath Bera, Yusuke Shiozawa, Lanying Zhao, June Takeda, Yosaku Watatani, Rurika Okuda, Hideki Makishima, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Masashi Sanada, Akifumi Takaori-Kondo, Satoru Miyano, Seishi Ogawa, Lee-Yung Shih
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
In chronic myeloid leukaemia (CML), the drivers of blast crisis and resistance to tyrosine kinase inhibitors are not fully characterised. Here, the authors analyse a cohort of CML samples with genomic technologies and find that at least one driver al
Externí odkaz:
https://doaj.org/article/b8463e0b7aef42f9abaf389f4f41e7bd
Autor:
Yotaro Ochi, Nobuhiro Hiramoto, Tetsuichi Yoshizato, Yuichiro Ono, June Takeda, Yusuke Shiozawa, Kenichi Yoshida, Nobuyuki Kakiuchi, Yuichi Shiraishi, Hiroko Tanaka, Kenichi Chiba, Yasuhiro Kazuma, Sumie Tabata, Noboru Yonetani, Keiichiro Uehara, Daisuke Yamashita, Yukihiro Imai, Koji Nagafuji, Mitsunori Yamakawa, Satoru Miyano, Akifumi Takaori-Kondo, Seishi Ogawa, Takayuki Ishikawa
Publikováno v:
Haematologica, Vol 103, Iss 11 (2018)
Externí odkaz:
https://doaj.org/article/26fe60a2ffc14949b09bf655a555346a